.

BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Chubb
Queensland Health
Mallinckrodt
Deloitte
Argus Health
US Army
Medtronic
Chinese Patent Office
Julphar

Generated: September 26, 2017

DrugPatentWatch Database Preview

Mupirocin calcium - Generic Drug Details

« Back to Dashboard

What are the generic sources for mupirocin calcium and what is the scope of mupirocin calcium patent protection?

Mupirocin calcium
is the generic ingredient in two branded drugs marketed by Glaxosmithkline and Glenmark Pharms Inc, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

There are twelve drug master file entries for mupirocin calcium. Nine suppliers are listed for this compound.

Summary for Generic Name: mupirocin calcium

Tradenames:2
Patents:0
Applicants:2
NDAs:3
Drug Master File Entries: see list12
Suppliers / Packagers: see list9
Bulk Api Vendors: see list54
Clinical Trials: see list1,830
Patent Applications: see list6,695
Therapeutic Class:Antibacterials
Drug Prices:see low prices
DailyMed Link:mupirocin calcium at DailyMed

Pharmacology for Ingredient: mupirocin calcium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline
BACTROBAN
mupirocin calcium
OINTMENT;NASAL050703-001Sep 18, 1995RXYesYes► Subscribe► Subscribe► Subscribe
Glenmark Pharms Inc
MUPIROCIN
mupirocin calcium
CREAM;TOPICAL201587-001Jan 24, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
Glaxosmithkline
BACTROBAN
mupirocin calcium
CREAM;TOPICAL050746-001Dec 11, 1997ABRXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: mupirocin calcium

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxosmithkline
BACTROBAN
mupirocin calcium
OINTMENT;NASAL050703-001Sep 18, 1995► Subscribe► Subscribe
Glaxosmithkline
BACTROBAN
mupirocin calcium
CREAM;TOPICAL050746-001Dec 11, 1997► Subscribe► Subscribe
Glaxosmithkline
BACTROBAN
mupirocin calcium
CREAM;TOPICAL050746-001Dec 11, 1997► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
Merck
Chubb
McKinsey
AstraZeneca
Teva
McKesson
Argus Health
Johnson and Johnson
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot